Introduction to Antidepressant Pharmacology Antidepressant drugs represent a fundamental pillar in the pharmacological management of Major Depressive Disorder (MDD) and a spectrum of other debilitating psychiatric conditions, including various anxiety disorders, obsessive-compulsive disorder (OCD), and chronic pain syndromes. Their clinical utility stems from their ability to modulate specific neurotransmitter systems within the central nervous system […]
Introduction and Historical Context of Antipsychotic-Associated Movement Disorders Antipsychotic-associated movement disorders represent a significant category of adverse drug reactions resulting from the pharmacological intervention used to treat severe psychiatric conditions, primarily schizophrenia and bipolar disorder. These disorders are often collectively referred to as extrapyramidal side effects (EPS) because they involve the extrapyramidal motor system, a […]
Introduction to Attitudes toward Antipsychotics Attitudes toward antipsychotic medications represent a complex and multifaceted domain within psychiatric care, encompassing the beliefs, emotional responses, and evaluative judgments held by patients, clinicians, families, and the wider public regarding these pharmacological interventions. These attitudes are not merely passive opinions; they are powerful psychological constructs that fundamentally influence treatment […]